drugset / Trial / NCT02705768

Effect of Carbamazepine and Oxcarbazepine on Serum Neuron-specific Enolase and S100B in Focal Seizures

NCT02705768

RandomizedParallel-groupOpen-labelTreatment

Summary

The present study has been planned to assess the level of serum neuron-specific enolase (NSE) in focal seizures and its changes after antiepileptic therapy.

Timeline

Start
2016-04
Primary completion
2017-02
Completion
2017-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Carbamazepine Small molecule 600 mg Oral
Subject Oxcarbazepine Small molecule 20 mg/kg Oral

Indications